CURO Group Holdings Corp. (CURO) Trades at $17.25 After Triangle; Swedbank Has Lowered Merck & Co Inc/N (MRK) Stake By $7.28 Million

Merck & Co., Inc. (NYSE:MRK) Logo

CURO Group Holdings Corp. (CURO) formed triangle with $18.29 target or 6.00% above today’s $17.25 share price. CURO Group Holdings Corp. (CURO) has $785.93M valuation. The stock decreased 0.52% or $0.09 during the last trading session, reaching $17.25. About 1,869 shares traded. CURO Group Holdings Corp. (NYSE:CURO) has 0.00% since April 4, 2017 and is . It has underperformed by 11.55% the S&P500.

Swedbank decreased Merck & Co Inc/N (MRK) stake by 3.46% reported in 2017Q4 SEC filing. Swedbank sold 130,015 shares as Merck & Co Inc/N (MRK)’s stock declined 4.63%. The Swedbank holds 3.63 million shares with $203.99 million value, down from 3.76M last quarter. Merck & Co Inc/N now has $144.73 billion valuation. The stock decreased 0.76% or $0.41 during the last trading session, reaching $53.68. About 1.06 million shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since April 4, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Analysts await CURO Group Holdings Corp. (NYSE:CURO) to report earnings on May, 3. CURO’s profit will be $30.53 million for 6.44 P/E if the $0.67 EPS becomes a reality. After $0.33 actual earnings per share reported by CURO Group Holdings Corp. for the previous quarter, Wall Street now forecasts 103.03% EPS growth.

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on May, 1. They expect $0.99 EPS, up 12.50% or $0.11 from last year’s $0.88 per share. MRK’s profit will be $2.67B for 13.56 P/E if the $0.99 EPS becomes a reality. After $0.98 actual EPS reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 1.02% EPS growth.

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 18 have Buy rating, 0 Sell and 6 Hold. Therefore 75% are positive. Merck & Co. Inc. had 82 analyst reports since August 13, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Monday, October 23 by Leerink Swann. The rating was maintained by UBS with “Buy” on Friday, August 19. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Outperform” rating by Credit Suisse on Monday, February 5. Morgan Stanley maintained Merck & Co., Inc. (NYSE:MRK) on Wednesday, February 7 with “Equal-Weight” rating. Barclays Capital upgraded Merck & Co., Inc. (NYSE:MRK) on Tuesday, December 1 to “Overweight” rating. The rating was downgraded by SunTrust to “Hold” on Monday, October 30. The firm has “Overweight” rating by Barclays Capital given on Friday, September 9. The firm has “Buy” rating by Bank of America given on Tuesday, November 28. Morgan Stanley upgraded Merck & Co., Inc. (NYSE:MRK) on Thursday, January 12 to “Overweight” rating. As per Tuesday, June 6, the company rating was maintained by BMO Capital Markets.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart